Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21EL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,792
Award facts
- Contract value 100% obligated
- $44,792.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $44.8K delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 23, 2026, for the supply of IMFINZI 500 mg/10 mL vials. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 13, 2026, and performance at the contractor's facility in Conshohocken, Pennsylvania. IMFINZI (durvalumab) is an oncology pharmaceutical used in cancer treatment, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement.
This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9M through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. The parent company, Cencora, Inc., holds an expanded IDC with DLA valued at up to $999.9M through December 31, 2031. AmerisourceBergen's continued awards for specialized medications reflect its established capability to compete successfully on an open basis and efficiently fulfill critical pharmaceutical requirements for military treatment facilities and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F21EL?
SPE2DR26F21EL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F21EL worth?
The government has obligated $44,792 on SPE2DR26F21EL.
Is contract SPE2DR26F21EL an order under another contract?
Yes. SPE2DR26F21EL is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21EL competed?
The extent of competition for SPE2DR26F21EL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award